JAK1/2 Inhibitor Ruxolitinib for the Treatment of Systemic Chronic Active Epstein-Barr Virus Disease: A Phase II Study

Published: 11/04/2024

… The only curative treatment is allogeneic hematopoietic stem cell transplantation
(allo-HSCT). Disease activity defined by multiple inflammatory symptoms is associated …